Skip To Main Content
Nitchakarn Laichuthai on Muck Rack

Nitchakarn Laichuthai

As seen in: Nature, Diabetes Care Magazine, Diabetes Magazine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Nitchakarn

Contact Nitchakarn, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Mobile application-based lifestyle intervention versus standard care for diabetes prevention in healthcare personnel with prediabetes: a randomized controlled trial

|
By Natnicha Houngngam, Prangareeya Santisitthanon, Nitchakarn Laichuthai, Panudda Srichomkwun, Natthaphon Wonghakaeo, Jutipond Jitchana, Sitamanats Suwanachaiy, Chalisa Rattanabumrung
| Nature Verified
Abstract Prediabetes increases the risk of progression to type 2 diabetes (T2DM). This study evaluated the efficacy of a mobile application-based lifestyle intervention compared with standard care in individuals with prediabetes. In this open-label randomized controlled trial, healthcare personnel with prediabetes at a tertiary-care hospital in Bangkok, Thailand, were randomly assigned to either a mobile application–based intervention or standard care.
Open in Who Shared Issue with article?

Newly Discovered Abnormal Glucose Tolerance in Patients With Acute Myocardial Infarction and Cardiovascular Outcomes: A Meta-analysis

|
By Nitchakarn Laichuthai, Muhammad Abdul-Ghani, Mikhail Kosiborod
| Diabetes Care Magazine Verified
Meta-analyses Abstract BACKGROUND The prevalence of unrecognized abnormal glucose tolerance (AGT) and the incidence of recurrent cardiovascular (CV) events in patients with acute myocardial infarction (MI) has not been systematically evaluated. PURPOSE The purposes of this study were to define the prevalence of newly discovered AGT and examine the risk of recurrent major adverse cardiac events (MACE) and mortality in patients with acute MI.
Open in Who Shared Issue with article?

Evidence Against an Important Role of Plasma Insulin and Glucagon Concentrations in the Increase in EGP Caused by SGLT2 Inhibitors

|
By Robert Martinez, Mariam Alatrach, Nitchakarn Laichuthai
| Diabetes Magazine Verified
Pathophysiology Abstract Sodium–glucose cotransport 2 inhibitors (SGLT2i) lower plasma glucose but stimulate endogenous glucose production (EGP). The current study examined the effect of dapagliflozin on EGP while clamping plasma glucose, insulin, and glucagon concentrations at their fasting level. Thirty-eight patients with type 2 diabetes received an 8-h measurement of EGP ([3-3H]-glucose) on three occasions.
Open in Who Shared Issue with article?
See all 3 articles